Short-Term Administration of the CCR5 Antagonist Vicriviroc to Patients With HIV and HCV Coinfection Is Safe and Tolerable

Gerd Fätkenheuer, Dirk Schürmann, Jihad Slim et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2009

Cited by 8